Frontiers in physiology · 2026
Decoding vascular calcification-neutrophil signature in pathogenesis of chronic IgA nephropathy: evidence from artificial intelligence-driven multi-omics and in vitro validation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cao Chunyu, Yan Wencheng, Li Mingyue, Lu Jing
Аннотация
BACKGROUND: Dysregulation of neutrophil and consistent vascular calcification(VC) contributes to the pathogenesis and progression of chronic IgA nephropathy(C-IgAN). However, its integrated mechanism in IgAN has not yet been elucidated.
METHODS: We integrated GSVA, CIBERSORT and WGCNA algorithms in C-IgAN patient bulk profiles(GSE35487 and GSE93798) downloaded from GEO database for identified VC and neutrophil (VN)-related shared DEGs. Next, explainable and systemic machine learning algorithms in C-IgAN training and validation bulk profiles identified VN-associated diagnostic model and hub gene. In addition, based on VN-associated shared gene signature, we performed NMF analysis for identification of VN-related molecular subgroups, and then we also investigated the molecular and immune patterns between subgroups. Besides, we also investigated hub gene, VC and neutrophil molecular landscapes at C-IgAN patient single-cell level via advanced analytical frameworks, such as sctenifoldknk and Bayes-prism algorithms. Novelty, deep learning algorithm (DrugRefLector) and molecular docking based on C-IgAN identified optimal therapeutic agent targeting hub gene. Finally, in vitro assays examined the expression pattern of hub gene.
RESULTS: Our study first traced dynamic VN patterns in C-IgAN and identified VN-associated diagnostic and molecular subgroups. Besides, CLEC4D can be considered as neutrophil-distributed hub gene involved in VC and C-IgAN pathogenesis, which also can be considered as a drug target of BRD-K27184429 in C-IgAN.
CONCLUSION: Our study first identified VN-related patterns for C-IgAN patients, which provides novel idea into clinical applications.
METHODS: We integrated GSVA, CIBERSORT and WGCNA algorithms in C-IgAN patient bulk profiles(GSE35487 and GSE93798) downloaded from GEO database for identified VC and neutrophil (VN)-related shared DEGs. Next, explainable and systemic machine learning algorithms in C-IgAN training and validation bulk profiles identified VN-associated diagnostic model and hub gene. In addition, based on VN-associated shared gene signature, we performed NMF analysis for identification of VN-related molecular subgroups, and then we also investigated the molecular and immune patterns between subgroups. Besides, we also investigated hub gene, VC and neutrophil molecular landscapes at C-IgAN patient single-cell level via advanced analytical frameworks, such as sctenifoldknk and Bayes-prism algorithms. Novelty, deep learning algorithm (DrugRefLector) and molecular docking based on C-IgAN identified optimal therapeutic agent targeting hub gene. Finally, in vitro assays examined the expression pattern of hub gene.
RESULTS: Our study first traced dynamic VN patterns in C-IgAN and identified VN-associated diagnostic and molecular subgroups. Besides, CLEC4D can be considered as neutrophil-distributed hub gene involved in VC and C-IgAN pathogenesis, which also can be considered as a drug target of BRD-K27184429 in C-IgAN.
CONCLUSION: Our study first identified VN-related patterns for C-IgAN patients, which provides novel idea into clinical applications.